OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post-vaccination neutralization responses to Omicron sub-variants
Henning Jacobsen, Maeva Katzmarzyk, Melissa M. Higdon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Henning Jacobsen, Maeva Katzmarzyk, Melissa M. Higdon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Showing 7 citing articles:
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 906-906
Open Access | Times Cited: 1
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 906-906
Open Access | Times Cited: 1
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay
Marta Fogolari, Bruno Daniele Leoni, Marina De Cesaris, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 889-889
Open Access | Times Cited: 2
Marta Fogolari, Bruno Daniele Leoni, Marina De Cesaris, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 889-889
Open Access | Times Cited: 2
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1238-1238
Open Access
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1238-1238
Open Access
The Re-Emergence of COVID-19 in 2022 Has Affected People’s Views on Vaccines
Yufei Wu, Huanjie Li, Yunshan Wang
Vaccines (2022) Vol. 10, Iss. 11, pp. 1974-1974
Open Access | Times Cited: 1
Yufei Wu, Huanjie Li, Yunshan Wang
Vaccines (2022) Vol. 10, Iss. 11, pp. 1974-1974
Open Access | Times Cited: 1
Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
Haruki Wakai, Natsumi Abe, Touno Tokuda, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access
Haruki Wakai, Natsumi Abe, Touno Tokuda, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access
